Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation
-
Radek Pudil
Abstract
Background: In a prospective study, we measured plasma markers of myocardial damage induced by radiofrequency catheter ablation (RFA) with the protein biochip microarray system.
Methods: A total of 32 consecutive patients undergoing RFA for atrioventricular nodal re-entry tachycardia (AVNRT), right atrial flutter (AFL) and atrial fibrillation (AF) were included in the study. Cardiac troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), heart-type fatty acid binding protein (hFABP) and glycogen phosphorylase BB (GPBB) were measured using biochip array technology at baseline and 24 h after the procedure.
Results: Values for all markers increased 24 h after RFA (cTnI: 0.92±0.49 μg/L vs. 0.33±0.06 μg/L, p<0.001; CK-MB: 3.79±2.04 μg/L vs. 1.85±0.55 μg/L, p<0.001; hFABP: 2.82±0.95 μg/L vs. 2.00±0.95 μg/L, p<0.001; GPBB: 9.07±5.83 μg/L vs. 4.70±2.50 μg/L, p<0.001). The correlations between plasma marker levels and RFA time were cTnI: r=0.63, p<0.01; CK-MB: r=0.75, p<0.01; hFABP: r=0.55, p<0.05, GPBB: r=0.51, p<0.05; the correlation between RFA time and number of RF applications was significant (r=0.81, p<0.001). Patients with RFA due to AF or flutter had elevated cTnI, CK-MB and hFABP levels compared to patients with AVNRT (cTnI: 1.14± 0.49 μg/L vs. 0.59±0.25 μg/L, p<0.05; CK-MB: 4.46± 2.07 μg/L vs. 2.81±1.54 μg/L, p<0.05; hFABP: 3.21± 0.98 μg/L vs. 2.25±0.54 μg/L, p<0.01).
Conclusions: Myocardial injury induced by RFA can be detected by cTnI, CK-MB, hFABP and GPBB. Plasma cTnI, CK-MB and hFABP levels significantly increased in patients with AFL and AF compared to patients with AVNRT. The increase of cTnI, CK-MB and GPBB levels correlates with the total duration of RFA.
Clin Chem Lab Med 2008;46:1726–8.
©2008 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editors' and Publisher's Note
- CCLM Award for the most cited paper recently published
- Reviews
- Cystatin C: current position and future prospects
- Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis
- Genetics and Molecular Diagnostics
- Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition
- Identification of two de novo mutations in Chinese patients with X-linked adrenoleukodystrophy
- CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation
- Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan
- Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking
- Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation
- An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach
- General Clinical Chemistry and Laboratory Medicine
- Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero line
- Accurate assessment and identification of naturally occurring cellular cobalamins
- Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction
- Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia
- Determination of carbohydrate-deficient transferrin (CDT) in Italy
- Validation and Outcome Studies
- Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment
- Validation of a novel ELISA for measurement of electronegative low-density lipoprotein
- Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population
- Introduction of non-linearity by data transformation in method comparison and commutability studies
- Reliability and correlation study of a new homocysteine assay
- Letters to the Editor
- Prevention of preanalytical false-positive increases of cardiac troponin I on the Unicel® DxI 800 analyzer
- Does carbamylated hemoglobin still affect the analysis of HbA1c in uremic and hyperglycemic patients?
- Recombinant immunoblot for assessment of intrathecally synthesised paraneoplastic antineuronal antibodies in cerebrospinal fluid from patients with paraneoplastic neurological syndromes
- Detection of duplicates and redundancies. A major responsibility of peer-reviewers?
- Erratum
- Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
- Acknowledgement
- Acknowledgements
- Contents
- Contents, Volume 46, 2008
- Author Index
- Author Index
- Subject Index
- Subject Index
Articles in the same Issue
- Editors' and Publisher's Note
- CCLM Award for the most cited paper recently published
- Reviews
- Cystatin C: current position and future prospects
- Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis
- Genetics and Molecular Diagnostics
- Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition
- Identification of two de novo mutations in Chinese patients with X-linked adrenoleukodystrophy
- CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation
- Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan
- Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking
- Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation
- An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach
- General Clinical Chemistry and Laboratory Medicine
- Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero line
- Accurate assessment and identification of naturally occurring cellular cobalamins
- Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction
- Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia
- Determination of carbohydrate-deficient transferrin (CDT) in Italy
- Validation and Outcome Studies
- Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment
- Validation of a novel ELISA for measurement of electronegative low-density lipoprotein
- Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population
- Introduction of non-linearity by data transformation in method comparison and commutability studies
- Reliability and correlation study of a new homocysteine assay
- Letters to the Editor
- Prevention of preanalytical false-positive increases of cardiac troponin I on the Unicel® DxI 800 analyzer
- Does carbamylated hemoglobin still affect the analysis of HbA1c in uremic and hyperglycemic patients?
- Recombinant immunoblot for assessment of intrathecally synthesised paraneoplastic antineuronal antibodies in cerebrospinal fluid from patients with paraneoplastic neurological syndromes
- Detection of duplicates and redundancies. A major responsibility of peer-reviewers?
- Erratum
- Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
- Acknowledgement
- Acknowledgements
- Contents
- Contents, Volume 46, 2008
- Author Index
- Author Index
- Subject Index
- Subject Index
